Blog
RSS FeedPosted by Michael Wonder on 05 Aug 2022
Australia secures new third generation monkeypox virus vaccine
4 August 2022 - The Albanese Government has secured 450,000 doses of the new third generation monkeypox virus vaccine by Bavarian ...
Posted by Michael Wonder on 04 Aug 2022
Vaxcyte provides positive regulatory updates for VAX-24 adult and paediatric programs
4 August 2022 - Company receives FDA fast track designation for VAX-24 in adults. ...
Posted by Michael Wonder on 03 Aug 2022
Supply a factor in restricting COVID vaccines for babies and toddlers
3 August 2022 - Most parents of babies and toddlers will not be able to access a COVID vaccine approved ...
Posted by Michael Wonder on 03 Aug 2022
COVID-19 vaccination for children aged 6 months to under 5 years
3 August 2022 - The Albanese Government has accepted a recommendation from the Australian Technical Advisory Group on Immunisation to make ...
Posted by Michael Wonder on 03 Aug 2022
COVID-19 vaccines undergoing evaluation (3 August 2022)
3 August 2022 - The TGA has published a list (table) of the COVID-19 vaccines currently under evaluation by the agency. ...
Posted by Michael Wonder on 03 Aug 2022
TGA commences evaluation of Pfizer's COVID-19 vaccine (Comirnaty) for children aged 6 months to less than 5 years
3 August 2022 - The TGA has commenced evaluation of an application from Pfizer to extend the use of its ...
Posted by Michael Wonder on 02 Aug 2022
SK bioscience submits application for conditional marketing authorisation of COVID-19 vaccine, SKYCovion to European Medicines Agency
1 August 2022 - SK bioscience will accelerate to apply for emergency use listing to the World Health Organization. ...
Posted by Michael Wonder on 31 Jul 2022
FDA provides update on agency response to monkeypox outbreak
29 July 2022 - Today, the U.S. FDA is providing an update on its multi-pronged response to monkeypox in the United ...
Posted by Michael Wonder on 28 Jul 2022
COVID-19 vaccine safety report (28 July 2022)
29 July 2022 - To 24 July 2022, the TGA has received 615 reports which have been assessed as likely to ...
Posted by Michael Wonder on 27 Jul 2022
Agenda for the November 2022 PBAC meeting
27 July 2022 - The agenda for the November 2022 PBAC meeting is now available. ...
Posted by Michael Wonder on 25 Jul 2022
TGA provisionally approves the Biocelect (Novavax) COVID-19 vaccine, Nuvaxovid, for use in individuals aged 12-17 years
25 July 2022 - The TGA has provisionally approved the Biocelect (on behalf of Novavax) COVID-19 vaccine, Nuvaxovid, for use in ...
Posted by Michael Wonder on 24 Jul 2022
Calls for PHARMAC to fund more effective shingles vaccine with cases expected to rise due to COVID-19
24 July 2022 - There are calls from medical experts for PHARMAC to fund a more effective vaccine for shingles, ...
Posted by Michael Wonder on 23 Jul 2022
EMA CHMP recommends use of the Moderna COVID-19 booster in adolescents (12-17 Years) in the European Union
22 July 2022 - Moderna today announced that the EMA's CHMP has adopted a positive opinion recommending a variation to ...
Posted by Michael Wonder on 23 Jul 2022
EMA recommends approval of Imvanex for the prevention of monkeypox disease
22 July 2022 - The EMA’s has recommended extending the indication of the smallpox vaccine Imvanex to include protecting adults ...
Posted by Michael Wonder on 21 Jul 2022
Pfizer announces Prevnar 20 (pneumococcal 20 valent conjugate vaccine) is now available in Canada for the prevention of pneumonia and invasive pneumococcal disease in adults 18 years of age and older
21 July 2022 - Prevnar 20 is the first conjugate vaccine indicated to help protect against 20 serotypes responsible for ...